Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Report of clinical findings in the vitreo-retinal diseases

Trial Profile

Report of clinical findings in the vitreo-retinal diseases

Phase of Trial: Phase IV

Latest Information Update: 23 May 2017

At a glance

  • Drugs Ranibizumab (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2017 New trial record
    • 01 Apr 2017 Status changed from recruiting to completed, according to the results published in the Medicine.
    • 01 Apr 2017 Results published in the Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top